Skip to content

Clinical observation of non-ablative fractional laser combined with hormone injection in the sequential treatment of hypertrophic burn scars in children

Clinical observation of non-ablative fractional laser combined with hormone injection in the sequential treatment of hypertrophic burn scars in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097051
Enrollment
Unknown
Registered
2025-02-11
Start date
2023-04-04
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic scar

Interventions

Combination group:Ultrasound measurements of scar thickness will be conducted, with triamcinolone injection therapy initiated when the scar thickness is greater than or equal to 3 mm. For scars with a
Laser group :Non-ablative fractional laser treatment will be administered, with each session scheduled at one-month intervals.
Injection group:Triamcinolone injection therapy will be administered, with each treatment session scheduled at intervals of 2 to 5 weeks.

Sponsors

Children’ s Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Children with post-burn hypertrophic scars who are seen in our hospital (meet the diagnostic criteria for hypertrophic scars in Modern Scarscience); 2. Age 2-14 years old; 3. The wound is completely healed; 4. There is no infection, eczema or other skin diseases on the skin around the scar; 5. Scar area 7 points.

Exclusion criteria

Exclusion criteria: 1. Patients with keloids; 2. Old scars that have been in treatment for more than 1 year from the time of injury to the start of treatment; 3. Extra-large scars throughout the body; 4. Accompanied by systemic diseases such as coagulation dysfunction and diabetes; 5. Children and their families have poor compliance or inconvenient follow-up.

Design outcomes

Primary

MeasureTime frame
Modified Vancouver Scar Scale score;Efficacy;

Secondary

MeasureTime frame
Numeric rating scale scores;Satisfaction ratings;

Countries

China

Contacts

Public ContactQiu Lin

Children's Hospital of Chongqing Medical University

qiulin118@126.com+86 186 0235 7299

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026